ArticleLipids in health and disease2021

Metabolic profiling reveals interleukin-17A monoclonal antibody treatment ameliorate lipids metabolism with the potentiality to reduce cardiovascular risk in psoriasis patients.

Han Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.